BioBoard
•  Korea's Stem-Cell Pioneer not told that Donor's Eggs are Paid
•  US$88 Million Expansion Plan for NUS Medical Faculty
•  Australia Reviews its Legislation on Stem Cells Research
•  Neuren Signs Agreement for Participation in Phase 3 Trial
•  Peptech Chairman Receive Prestigious Award
•  Accelovance Enter China Market
•  Vasudeva Ayurvedic Sets Up Herbal Formulation Plant
•  Premier Bionics Partners with Medic Vision
•  Nippon Sheet Glass Collaborates with Kagome and Kajima

Special Feature
•  Bioengineering Peptide Antibiotics
•  Dry Eye - Concepts and Therapeutic Advances
•  The Singapore Malay Eye Study: Understanding Racial/Ethnic Variations in Eye Diseases

Industry Watch
•  Aspect Medical Systems and Brain Resource Company Partners in MCI Study
•  Mesoblast and Cordis Collaborate on Adult Stem Cell Heart Trial
•  Apollo Life Sciences Begins Sale of Human Cell-Expressed Proteins Globally
•  Workhardt Introduces Hepatitis A Vaccine into Indian Market
•  Transgene Biotek Develops Oral Delivery of Insulin and Hepatitis B Vaacine
•  Japan's Bioventures Today - Peruseus Proteomics Inc

Products / Services Highlights
•  Tissue Science Laboratories Introduces Permacol^®
•  Positive Clinical Results for Permacol^® as a Dermal Filler

Commentaries & Analyses
•  Snapshot of Current Australian Biotechnology Boom Indicators
(by M. Muralitharan, S. Agricola, T. Coulepis, S. Chandler and C. Gray)

Alternative Medicine
•  Harmonization of Traditional and Modern Medicine: An Australian Perspective

General News
•  CIA 2005

Conference Calendar